News
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
Does BioNTech SE Sponsored ADR (BNTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Market Catalysts host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute. Arm ...
Bristol Myers Squibb posted much better-than-expected second-quarter results on Wednesday on strong sales of its most ...
Bristol Myers Squibb reported unexpectedly strong second-quarter results, driven by legacy products like Eliquis, despite ...
Bristol Myers Squibb surpassed analyst expectations with a strong Q2, as notable brands Eliquis, Opdivo, and Revlimid drove ...
Bristol-Myers Squibb (BMY) shares rise after beating Q2 forecasts, raising 2025 revenue outlook, and showcasing growth in key ...
One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...
AbbVie's beat Wall Street's estimates for its top- and bottom-lines in the second quarter, boosted by sales of Skyrizi and Rinvoq. S&P Global said second-quarter profit rose due to "resilience in the ...
By Michael Erman and Bhanvi Satija (Reuters) -Bristol Myers Squibb posted much better-than-expected second-quarter results on ...
Gene Therapy Market Gene therapy market surges on breakthroughs in genome editing, rising chronic & genetic disease cases, regulatory appro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results